Literature DB >> 26628475

CNS Metastases in Patients With Non-Small-Cell Lung Cancer and ALK Gene Rearrangement.

Wenyin Shi1, Adam P Dicker2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26628475     DOI： 10.1200/JCO.2015.63.9682

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Systemic therapy for echinoderm microtubule-associated protein-like 4 anaplastic lymphoma kinase non-small cell lung cancer brain metastases.

Authors:  Jenny Guo; Ralph Zinner; Nicholas G Zaorsky; Wei Guo; Bo Lu
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 2.  Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options.

Authors:  Meysam Yousefi; Tayyeb Bahrami; Arash Salmaninejad; Rahim Nosrati; Parisa Ghaffari; Seyed H Ghaffari
Journal:  Cell Oncol (Dordr)       Date:  2017-09-18       Impact factor: 6.730

3.  Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain Barrier.

Authors:  Minjee Kim; Daniel J Ma; David Calligaris; Shuangling Zhang; Ryan W Feathers; Rachael A Vaubel; Isabelle Meaux; Ann C Mladek; Karen E Parrish; Fang Jin; Cedric Barriere; Laurent Debussche; James Watters; Shulan Tian; Paul A Decker; Jeanette E Eckel-Passow; Gaspar J Kitange; Aaron J Johnson; Ian F Parney; Panos Z Anastasiadis; Nathalie Y R Agar; William F Elmquist; Jann N Sarkaria
Journal:  Mol Cancer Ther       Date:  2018-07-03       Impact factor: 6.261

Review 4.  Alectinib: A Review in Advanced, ALK-Positive NSCLC.

Authors:  Julia Paik; Sohita Dhillon
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

Review 5.  Updates in the management of brain metastases.

Authors:  Nils D Arvold; Eudocia Q Lee; Minesh P Mehta; Kim Margolin; Brian M Alexander; Nancy U Lin; Carey K Anders; Riccardo Soffietti; D Ross Camidge; Michael A Vogelbaum; Ian F Dunn; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2016-08       Impact factor: 12.300

6.  A CT-based radiomics model to predict subsequent brain metastasis in patients with ALK-rearranged non-small cell lung cancer undergoing crizotinib treatment.

Authors:  Yongluo Jiang; Yixing Wang; Sha Fu; Tao Chen; Yixin Zhou; Xuanye Zhang; Chen Chen; Li-Na He; Wei Du; Haifeng Li; Zuan Lin; Yuanyuan Zhao; Yunpeng Yang; Hongyun Zhao; Wenfeng Fang; Yan Huang; Shaodong Hong; Li Zhang
Journal:  Thorac Cancer       Date:  2022-04-18       Impact factor: 3.223

7.  Evaluation of ALK gene rearrangement in central nervous system metastases of non-small-cell lung cancer using two-step RT-PCR technique.

Authors:  M Nicoś; P Krawczyk; K Wojas-Krawczyk; A Bożyk; B Jarosz; M Sawicki; T Trojanowski; J Milanowski
Journal:  Clin Transl Oncol       Date:  2017-05-22       Impact factor: 3.405

Review 8.  Cystic brain metastases in ALK-rearranged non-small cell lung cancer.

Authors:  Guilherme Nader Marta; Renata Rodrigues da Cunha Colombo Bonadio; Renata Eiras Martins; Henrique Bortot Zuppani; Gilberto de Castro
Journal:  Ecancermedicalscience       Date:  2018-03-14

9.  A large, single-center, real-world study of clinicopathological characteristics and treatment in advanced ALK-positive non-small-cell lung cancer.

Authors:  Gang Chen; Xi Chen; Yaxiong Zhang; Fang Yan; Wenfeng Fang; Yunpeng Yang; Shaodong Hong; Siyu Miao; Manli Wu; Xiaodan Huang; Youli Luo; Cong Zhou; Run Gong; Yan Huang; Ningning Zhou; Hongyun Zhao; Li Zhang
Journal:  Cancer Med       Date:  2017-04-04       Impact factor: 4.452

10.  [Lorlatinib: a promising drug in the future treatment of advanced ALK-positive non-small-cell lung cancer].

Authors:  Johanna Richter; Jürgen Dunst
Journal:  Strahlenther Onkol       Date:  2021-06-10       Impact factor: 3.621
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.